DDrare: Database of Drug Development for Rare Diseases

Anti-tnf therapy (etanercept or adalimumab) (DrugBank: Etanercept, Adalimumab)

2 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
271	Ankylosing spondylitis	1

46. Malignant rheumatoid arthritis [ 4,183 clinical trials, 2,538 drugs, (DrugBank: 401 drugs), 183 drug target genes, 219 drug target pathways]

Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 4,183 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01060098 (ClinicalTrials.gov)	April 2010	29/1/2010	T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade	T Cells and TNF: The Impact of TNF Blockade on Effector T Cell Populations in Rheumatoid Arthritis and Other Conditions Treated With Anti-TNFalpha Agents	Rheumatoid Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis	Drug: anti-TNF therapy (etanercept or adalimumab)	Imperial College London	NULL	Completed	18 Years	80 Years	All	48		United Kingdom

271. Ankylosing spondylitis [ 531 clinical trials, 343 drugs, (DrugBank: 66 drugs), 41 drug target genes, 141 drug target pathways]

Searched query = "Ankylosing spondylitis", "Spondylarthritis ankylopoietica"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 531 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01060098 (ClinicalTrials.gov)	April 2010	29/1/2010	T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade	T Cells and TNF: The Impact of TNF Blockade on Effector T Cell Populations in Rheumatoid Arthritis and Other Conditions Treated With Anti-TNFalpha Agents	Rheumatoid Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis	Drug: anti-TNF therapy (etanercept or adalimumab)	Imperial College London	NULL	Completed	18 Years	80 Years	All	48		United Kingdom